Item 1A. Risk Factors
ITEM
1A. RISK FACTORS
Except
as set forth below, there have been no material changes from the risk factors previously disclosed in “Item 1A. Risk Factors”
of our 2024 Annual Report.
We
have in the past failed to maintain compliance with all applicable continued listing requirements of the Nasdaq Stock Market, and if
we fail to maintain compliance with all applicable continued listing requirements of the Nasdaq Capital Market in the future, we will
not be afforded traditional cure periods under Nasdaq rules and our Class A common stock may be delisted from Nasdaq, which could have
an adverse impact on the liquidity and market price of our common stock.
On
August 19, 2024, we received a delist notice from the Staff of Nasdaq notifying us that the listing of our Class A common stock was not
in compliance with the minimum market value of publicly held securities requirement and the minimum shareholders’ equity requirement
set forth in Nasdaq Listing Rules. On November 5, 2024, we received a delist notice from the Staff of Nasdaq notifying us that the listing
of our Class A common stock was not in compliance with the minimum bid price requirement of $1.00 per share set forth in Nasdaq Listing
Rules.
We
requested a hearing before a Nasdaq hearing panel (the “Panel”) to present a plan to regain compliance with all the continued
listing requirements of Nasdaq and such hearing was held May 15, 2025. On May 30, 2025, the Panel provided us an exception with various
milestones to regain compliance, including with Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”) until July 8, 2025
and the minimum shareholders’ equity requirement until July 30, 2025. In addition, the Panel directed that the listing of our Class
A common stock be transferred to the Nasdaq Capital Market, effective at the open of business on June 3, 2025.
On
July 17, 2025, the Staff confirmed that we had regained compliance with the Bid Price Rule as required by the Panel’s decision.
On August 1, 2025, we received a letter from Nasdaq notifying us that we had demonstrated compliance with Nasdaq Listing Rule 5550(b)(1)
(the “Equity Rule”), as required by the Panel’s decision, and, following our phase down to the Nasdaq Capital Market
on June 3, 2025, we demonstrated compliance with the minimum market value of publicly held securities required by Nasdaq Listing Rule
5550(a)(5).
Pursuant
to the letter, in application of Listing Rule 5815(d)(4)(B), we will be subject to a Mandatory Panel Monitor for a period of one year
from the date of the letter. If, within that one-year monitoring period, the Staff finds us again out of compliance with the Equity Rule,
notwithstanding Rule 5810(c)(2), we will not be permitted to provide the Staff with a plan of compliance with respect to that deficiency
and Staff will not be permitted to grant additional time for us to regain compliance with respect to that deficiency, nor will we be
afforded an applicable cure or compliance period pursuant to Rule 5810(c)(3). Instead, Staff will issue a delist determination letter
and we will have an opportunity to request a new hearing.
Delisting
from Nasdaq would adversely affect our ability to raise additional financing through the public or private sale of equity securities,
may significantly affect the ability of investors to trade our securities and may negatively affect the value and liquidity of our common
stock. Delisting also could have other negative results, including the potential loss of employee confidence, the loss of institutional
investors and general investors that will consider investing in our common stock, a reduction in the number of market makers in our common
stock, a reduction in the availability of information concerning the trading prices and volume of our common stock, a reduction in the
number of broker-dealers willing to execute trades in shares of our common stock or interest in business development opportunities. Further,
we would likely become a “penny stock”, which would make trading of our common stock more difficult.
The
conversion of our outstanding Series A Preferred Stock, or any additional shares of Series A PreferredStock we issue in the future upon
the exercise of the Series A Preferred Warrants, into Class A common stock will dilute the ownership interest of our stockholders.
Our
Series A Preferred Stock provide that if, while the Series A Preferred Stock are outstanding, we sell any Class A common stock and/or
Class A common stock equivalents other than in connection with certain exempt issuances, at a purchase price per share less than the
conversion price of the Series A Preferred Stock in effect immediately prior to such sale, then immediately after such sale the exercise
price of the Series A Preferred Stock then in effect will be reduced to an amount equal to the new issuance price, and, the number of
shares issuable upon conversion of the Series A Preferred Stock will be proportionately adjusted such that the aggregate price will remain
unchanged, subject to the floor price provided for in the Series A Preferred Stock. In addition, if on any six month anniversary after
the date the Series A Preferred Stock are issued (each, a “Reset Date”), the conversion price then in effect is greater than
the closing price of the Class A common stock as of such applicable Reset Date (each, a “Reset Price”), immediately after
the close of trading on such applicable Reset Date the conversion price shall automatically lower to the Reset Price. Finally, if at
any time on or after the date of issuance there occurs any stock split, stock dividend, stock combination recapitalization or other similar
transaction involving the Class A common stock, the conversion price shall be reduced to 120% of the quotient determined by dividing
(x) the sum of the volume weighted average price of the Class A common stock for each of the five trading days with the lowest volume
weighted average price of the Class A common stock during the fifteen consecutive trading day period ending and including the trading
day immediately preceding the sixteenth trading day after such event date, divided by (y) five. If the conversion price of the Series
A Preferred Stock decreases, the number of shares underlying the Series A Preferred Stock will increase, which would materially dilute
the ownership of our stockholders.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.